Detection of serum insulin-like growth factor binding proteins on Western ligand blots by biotinylated IGF and enhanced chemiluminescence

被引:15
作者
DeBeeck, LO [1 ]
Verlooy, JEA [1 ]
VanBuulOffers, SC [1 ]
DuCaju, MVL [1 ]
机构
[1] UNIV UTRECHT,WILHELMINA CHILDRENS HOSP,NL-3501 CA UTRECHT,NETHERLANDS
关键词
D O I
10.1677/joe.0.154R001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A novel procedure for the detection of IGF binding capacity of IGFBPs on Western ligand blots (WLB) was developed using biotinylated IGFs as probes. The biotinylated IGF-IGFBP complexes were visualized by streptavidin-horseradish peroxidase and enhanced chemiluminescence (ECL). The procedure was found to be faster and more efficient than the conventional method with iodinated IGFs. In normal human serum a predominant doublet at 38-42 kDa and five smaller bands at 35, 34, 30, 28 and 24 kDa were detected by both methods, whereas two additional bands at 26 and 16 kDa became visible with the ECL method. In pregnancy serum only one single faint band at 30 kDa could be detected by the iodinated method. In contrast, the ECL method revealed five other bands at 42, 34, 28, 26 and 16 kDa. Besides the 38-42 kDa doublet, the 30 and 16 kDa bands reacted strongly with anti-IGFBP-3 antibodies in Western immunoblotting (WIB) and therefore were related to IGFBP-3 fragments. The technical advantages of this ECL method include an extremely short exposure time to the radiographic film and a long stability of the probe. In addition, the ECL method is a non-radioactive method, making radioprotection and radioactive waste removal unnecessary.
引用
收藏
页码:R1 / R5
页数:5
相关论文
共 16 条
[11]   A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin [J].
Lalou, C ;
Lassarre, C ;
Binoux, M .
ENDOCRINOLOGY, 1996, 137 (08) :3206-3212
[12]   INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS [J].
RECHLER, MM .
VITAMINS AND HORMONES, VOL 47: ADVANCES IN RESEARCH AND APPLICATIONS, 1993, 47 :1-114
[13]  
SCHULLER AGP, 1993, GROWTH REGULAT, V3, P32
[14]   CHARACTERIZATION OF A LOW-MOLECULAR-MASS FORM OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (17.7 KILODALTONS) IN URINE AND SERUM FROM HEALTHY-CHILDREN AND GROWTH-HORMONE (GH)-DEFICIENT PATIENTS - RELATIONSHIP WITH GH THERAPY [J].
SPAGNOLI, A ;
GARGOSKY, SE ;
SPADONI, GL ;
MACGILLIVRAY, M ;
OH, Y ;
BOSCHERINI, B ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3668-3676
[15]   INSULIN-LIKE GROWTH FACTOR-(IGF) BINDING PROTEIN-3 IN PREGNANCY SERUM BINDS NATIVE IGF-I BUT NOT IODO-IGF-I [J].
SUIKKARI, AM ;
BAXTER, RC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (06) :1377-1379
[16]   ELECTROPHORETIC TRANSFER OF PROTEINS FROM POLYACRYLAMIDE GELS TO NITROCELLULOSE SHEETS - PROCEDURE AND SOME APPLICATIONS [J].
TOWBIN, H ;
STAEHELIN, T ;
GORDON, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (09) :4350-4354